Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Market Reports
A new way of buying and selling APIs, additives, vitamins and excipients
Swiss Kemiex and Atradius credit insurance launch unique commodity trading platform for the pharmaceutical and nutritional ingredients
The nanozyme that uses light to kill bacteria
Scientists at the RMIT University in Australia have created a nanozyme with antimicrobial properties with huge potential applications. Angharad Baldwin interviews Professor Vipul Bansal, lead researcher, to find out more
Six months and counting
With 6 months to go until the DSCSA serialisation enforcement deadline kicks in, <i>Manufacturing Chemist</i> caught up with some leading lights in the industry to find out how companies were shaping up ahead of November to mark the occasion
Invisible benefits
SCHOTT enhances its iQ platform with the introduction of the new syriQ BioPure glass syringe for sensitive drugs
Accelerating drug discovery
Angharad Baldwin of <i>Manufacturing Chemist</i> speaks to Dr Trevor Perrior, CSO of Domainex, about the development of a new GPCR drug discovery technology
The final countdown: CDMO focus areas before Feb 2019
Staffan Widengren will be presenting at <a href='https://www.tracelink.com/futurelink'>FutureLink Munich</a> on the <i>Final countdown: focus areas for a CDMO before February 2019</i>
How to boost the conversion rate of your e-commerce website in the manufacturing industry
Fifty three per cent of businesses spend less than 5% of their total marketing budget on boosting their conversion rates, and 35% of businesses have a conversion rate of less than 1%
Advances in medical technology
Overhauling operating models to create digital value
Tailor-made molecules for the drugs of tomorrow
Getting a drug to market is no easy feat, especially with tight regulations to comply with and the plethora of products that are already available. This is why a service that streamlines the discovery process and leads to improved outcomes during clinical trials for drug candidates is likely to be very desirable
PCI expands analytical laboratories at Tredegar site
Pharmaceutical outsourcing services provider PCI announces laboratory expansion at contained manufacturing centre
Standing strong
As regulatory pressure keeps rising, affecting every aspect of the drug manufacturing process, quality is an ongoing quest for pharma companies. Kevin Robinson spoke to Christina Rettig, Head of Communications at SCHOTT AG to find out more
Addressing glass particulates in injectable drug formulations
Glass particles are a frequent contaminant risk when producing injectable drugs on high speed filling lines. Glassmaker Corning has studied the root causes and engineered a new glass product for use on existing equipment that significantly reduces that risk
Serialisation: one year and counting
The Falsified Medicines Directive (FMD) introduces pan-European measures to prevent counterfeit medicines from entering the supply chain
A modern take on sterility assurance
Pharmaceutical manufacturers are increasingly looking for strategies to address containment risks. Christian Dunne of ChargePoint Technology sheds light on the benefit of split butterfly valve technology (SBV) in the aseptic processing of sterile active APIs and the final product
A look back at 2017 healthcare transactions
Last year, 2017, saw 2011 deals complete, with Q2 showing the strongest performance with 29.4%, followed by Q1 with 27.6%, Q3 with 24.1% and Q4 with 18.9%
Weathering the Brexit storm
The effective use of technology could facilitate regulatory compliance for pharmaceutical companies
Performance validation: HPAPI containment testing in a risk-based era
Taking a more automated approach to validation testing paves the way to capturing more repeatable and reliable data, thereby improving levels of containment performance
Gene transfer therapy approved for the treatment of ALL: part I
In August 2017, Novartis received FDA approval for its chimeric antigen receptor T (CAR-T) cell therapy, Kymriah, for the treatment of children and young adults with B-cell acute lymphoblastic leukaemia (ALL)
The race to be first: drug delivery systems for biosimilars
For biosimilar manufacturers, the market potential is significant, especially for those that are first to market
Improving cold chain performance and reliability
The need to mitigate risks within global pharmaceutical supply chain logistics is driving innovation within the temperature-controlled packaging sector
Previous
1
2
3
4
5
6
7
8
9
(current)
Next
Trending Articles
How to avoid sticking and picking in the tableting industry
John Norman and Kevin Queensen of Natoli Engineering explain
Peak identification by LC/MS: Automation versus analyst
High pressure liquid chromatography/mass spectrometry (LC/MS) is an important technique that facilitates the correct and accurate identification of impurities in pharmaceutical products and intermediates
Recombinant versus synthetic peptide synthesis: the perks and drawbacks
Since the introduction of novel peptide drugs into the market, the demand for polypeptide manufacturing has significantly increased, reports Dr Philipp Markolin
The modularisation of chemical API synthesis
The modularisation of chemical synthesis pathways in pharmaceutical production can improve overall plant efficiency and reduce planning time. Glatt Ingenieurtechnik has optimised the active pharmaceutical ingredient (API) synthesis process and developed bespoke plant designs for several international customers
How iPSCs can bridge the translational gap in neuroscience
Affecting more than one in three people, neurological disorders have a vast impact on global health while exacting a tremendous cost, reports Dr Max Mirza, Vice President of Neuroscience Drug Discovery at Sygnature Discovery
Upcoming event
EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications
16 January 2025 | Virtual
See all